McKesson Corporation Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by McKesson Corporation on May 28, 2024, with the earliest event reported on that date. The filing primarily addresses corporate governance changes, specifically the election of a new director and the departure of two existing directors effective at the 2024 Annual Meeting of Shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on governance matters and does not contain financial performance data.
Material Changes
- Director Election: The Board elected Deborah Dunsire, M.D., as a director, effective June 3, 2024. She has been appointed to the Compensation and Talent Committee and the Finance Committee.
- Director Departures: Linda Mantia and Susan R. Salka will not stand for re-election at the 2024 Annual Meeting. Their terms will expire effective at that meeting.
- Regulation FD Disclosure: A news release regarding these governance changes was issued on June 3, 2024.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business performance. No specific risks or contingencies related to operations or finances are disclosed in this document. Dr. Dunsire's compensation will follow standard policies for non-employee directors as described in the 2023 Proxy Statement.
Investor Verification Checklist
- Verify the exact date of the 2024 Annual Meeting of Shareholders to confirm the effective date of the departing directors' terms.
- Review the 2023 Proxy Statement to understand the specific compensation and indemnification policies applicable to Dr. Dunsire.
- Confirm the composition of the Compensation and Talent Committee and Finance Committee following Dr. Dunsire's appointment.
- Check the company's investor relations website for the full text of the June 3, 2024 news release (Exhibit 99.1).